Health Canada Issues License for Acuvue Oasys with Transitions Light Intelligent Technology
Johnson & Johnson Vision announced on Tuesday Acuvue Oasys with Transitions was issued a medical device license by Health Canada. The two-week reusable contact lens will be commercially available in the first half of 2019.
Acuvue Oasys with Transitions Light Intelligent Technology is a first-of-its-kind contact lens in Canada that offers benefits beyond vision correction by reducing exposure to bright light both indoors and outdoors.
“Acuvue Oasys with Transitions is the result of more than a decade of product development and numerous clinical trials involving more than 1,000 patients,” said Ted Lachmansingh, Canada Business Director, Johnson & Johnson Vision. “This first-of-its-kind contact lens was born out of deep research into consumer lifestyle needs and provides wearers with a solution to help manage light in their modern, active lives.”
Click HERE for the full press release.